The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
Open accessAbstract
Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstrated that antibodies against IL‐6 diminish tumour growth. Several reports have highlighted the prognostic importance of IL‐6 in e.g., prostate and colon cancer. We addressed prospectively the prognostic significance of serum IL‐6 (sIL‐6), measured at diagnosis of metastasis, in 96 unselected and consecutive patients with progressive metastatic breast cancer before the initiation of systemic therapy. The median sIL‐6 value for the breast cancer population was 6.6 ± 2.1 pg/ml. Patients with 2 or more metastatic sites had higher sIL‐6 values compared to those with only 1 metastatic site (respectively 8.15 ± 1.7 pg/ml and 3.06 ± 6.6 pg/ml; p < 0.001). Patients with liver metastasis (8.3 ± 2.4 pg/ml), with pleural effusions (10.65 ± 9.9 pg/ml) and with dominant visceral disease (8.15 ± 3.3 pg/ml) had significantly higher values compared to those without liver metastases (4.5 ± 3.4 pg/ml; p = 0.001), without pleural effusions (5.45 ± 1.5 pg/ml; p = 0.0077) and with dominant bone disease (4.5 ± 1.4 pg/ml; p = 0.007) respectively. No correlation between sIL‐6 and age, menopausal status, performance status, tumour grade, body‐mass index, histology and hormone receptor status was found. Multivariate analysis showed that high levels of serum IL‐6 have independent prognostic value. We conclude that circulating IL‐6 is associated with worse survival in patients with metastatic breast cancer and is correlated with the extent of disease. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Dankbar, B., Padró, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R. M., Serve, H., Berdel, W. E., & Kienast, J. (2000) · Blood · doi:10.1182/blood.v95.8.2630 · Cited by 566
(1996) · Nature Medicine · doi:10.1038/nm1196-1267 · Cited by 429
Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.12.4034 · Cited by 427
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., & Murai, M. (2000) · PubMed · Cited by 351
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.
Motro, B., Itin, A., Sachs, L., & Keshet, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3092 · Cited by 346
Zhang, G.-J., & Adachi, I. (1999) · PubMed · Cited by 306
George, M. L., Eccles, S. A., Tutton, M. G., Abulafi, A. M., & Swift, R. I. (2000) · PubMed · Cited by 233
Lu, C., & Kerbel, R. S. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.5.1281 · Cited by 224
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H., & Cole, D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.499 · Cited by 216
Dirix, L. Y., Salgado, R., Weytjens, R., Colpaert, C., Benoy, I., Huget, P., van Dam, P., Prové, A., Lemmens, J., & Vermeulen, P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600069 · Cited by 204
Self-citationBelluco, C., Nitti, D., Frantz, M., Toppan, P., Basso, D., Plebani, M., Lise, M., & Jessup, J. M. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0133-7 · Cited by 196
Badache, A., & Hynes, N. E. (2001) · PubMed · Cited by 189
Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., & Dirix, L. Y. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.008 · Cited by 188
Self-citationKinoshita, T., Ito, H., & Miki, C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990615)85:12<2526::aid-cncr6>3.0.co;2-3 · Cited by 169
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.
Schneider, M. R., Hoeflich, A., Fischer, J. R., Wolf, E., Sordat, B., & Lahm, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00401-2 · Cited by 167
Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Marck, E. V., & Dirix, L. Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690437 · Cited by 165
Self-citationDuan, Z., Feller, A. J., Penson, R. T., Chabner, B. A., & Seiden, M. V. (1999) · PubMed · Cited by 165
Interleukin-6 immunoreactivity in human tumors.
TABIBZADEH, S. S., Poubouridis, D., May, L. T., & Sehgal, P. B. (1989) · Europe PMC (PubMed Central) · Cited by 135
Breast Cancer and the Role of Cytokines in Regulating Estrogen Synthesis: An Emerging Hypothesis
Reed, M. J., & Purohit, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.5.0314 · Cited by 134
Serum Evaluation of Interleukin 6 in Ovarian Cancer Patients
Tempfer, C. M., Zeisler, H., Sliutz, G., Haeusler, G., Hanzal, E., & Kainz, C. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4726 · Cited by 133
Jee, S., Shen, S., Chiu, H., Tsai, W.-L., & Kuo, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204076 · Cited by 130
Loppnow, H., Bil, R., Hirt, S. W., Schönbeck, U., Herzberg, M., Werdan, K., Rietschel, E. T., Brandt, E., & Flad, H. (1998) · Blood · doi:10.1182/blood.v91.1.134 · Cited by 122
Nakano, T., Chahinian, A. P., Shinjyo, M., Tonomura, A., Miyake, M., Togawa, N., Ninomiya, K., & Higashino, K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.150 · Cited by 117
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma
Preti, H. A., Cabanillas, F., Talpaz, M., Tucker, S. L., Seymour, J. F., & Kurzrock, R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00002 · Cited by 112
Interleukin-6 activity in wounds
Mateo, R. B., Reichner, J. S., & Albina, J. E. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.6.r1840 · Cited by 111
Expression and function of interleukin‐6 in epithelial cells
Krueger, J. G., Ray, A., Tamm, I., & Sehgal, P. B. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240450404 · Cited by 110
Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells.
Fee, D. B., Grzybicki, D., Dobbs, M., Ihyer, S., Clotfelter, J., Macvilay, S., Hart, M., Sandor, M., & Fabry, Z. (2000) · Cytokine · doi:10.1006/cyto.1999.0599 · Cited by 107
Interleukin-6 in Cervical Cancer: The Relationship with Vascular Endothelial Growth Factor
Wei, L., Kuo, M., Chen, C., Cheng, W., Cheng, S.-P., Hsieh, F., & Hsieh, C. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6235 · Cited by 104
THE EFFECTS OF IL-6 ON CELL ADHESION AND E-CADHERIN EXPRESSION IN BREAST CANCER
Asgeirsson, K., Ólafsdóttir, K., Jonasson, J. G., & Ogmundsdottir, H. M. (1998) · Cytokine · doi:10.1006/cyto.1998.0349 · Cited by 101
Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.
Chiu, J., Sgagias, M. K., & Cowan, K. H. (1996) · PubMed · Cited by 99
Expression and function of members of the cytokine receptor superfamily on breast cancer cells
Douglas, A. M., Goss, G. A., Sutherland, R. L., Hilton, D. J., Berndt, M. C., Nicola, N. A., & Begley, C. G. (1997) · Oncogene · doi:10.1038/sj.onc.1200882 · Cited by 96
Vita, F. D., Romano, C. P., Orditura, M., Galizia, G., Martinelli, E., Lieto, E., & Catalano, G. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001459150 · Cited by 95
Serum viral interleukin-6 in AIDS-related multicentric Castleman disease
Aoki, Y., Tosato, G., Fonville, T. W., & Pittaluga, S. (2001) · Blood · doi:10.1182/blood.v97.8.2526 · Cited by 89
Ljungberg, B., Grankvist, K., & Rasmuson, T. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00179-2 · Cited by 89
Ohe, Y., Podack, E. R., Olsen, K. J., Miyahara, Y., Miura, K., Saitô, H., Koishihara, Y., Ohsugi, Y., Ohira, T., Nishio, K., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.174 · Cited by 79
IL-6 gene amplification and expression in human glioblastomas
Tchirkov, A., Rolhion, C., Bertrand, S., Doré, J. F., Dubost, J. J., & Verrelle, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1942 · Cited by 78
Legrand-Poels, S., Schoonbroodt, S., & Piette, J. G. (2000) · Biochemical Journal · doi:10.1042/bj3490765 · Cited by 77
Interleukin-6: a cytokine with potential diagnostic and therapeutic roles.
Ec, B., & Chin, P. (1994) · PubMed · Cited by 75
Danforth, D. N., & Sgagias, M. K. (1993) · PubMed · Cited by 69
In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells.
Sun, W. H., Kreisle, R. A., Phillips, A. W., & Ershler, W. B. (1992) · PubMed · Cited by 68
Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report
Yokoe, T., lino, Y., & Morishita, Y. (2000) · Breast Cancer · doi:10.1007/bf02967458 · Cited by 66
PEPTIDOGLYCAN PRIMES FOR LPS-INDUCED RELEASE OF PROINFLAMMATORY CYTOKINES IN WHOLE HUMAN BLOOD
Wang, J. E., Jørgensen, P. F., Ellingsen, E. A., Almlöf, M., Thiemermann, C., Foster, S. J., Aasen, A. O., & Solberg, R. (2001) · Shock · doi:10.1097/00024382-200116030-00002 · Cited by 66
Immunoregulatory Effects of Cytokines on Natural Killer Cells
Naume, B., & Espevik, T. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03441.x · Cited by 66
Utsumi, K., Takai, Y., Tada, T., Ohzeki, S., Fujiwara, H., & Hamaoka, T. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.397 · Cited by 65
Stone, S. F., Price, P., Brochier, J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323599 · Cited by 56
Expression of the interleukin 6 receptor in primary renal cell carcinoma.
Costes, V., Liautard, J., Picot, M., Robert, M., Lequeux, N., Brochier, J., Baldet, P., & Rossi, J. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.10.835 · Cited by 52
Giraudo, E., Arese, M., Toniatti, C., Strasly, M., Primo, L., Mantovani, A., Ciliberto, G., & Bussolini, F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2618 · Cited by 51
High Serum Interleukin-6 Levels Correlate with a Shorter Failure-Free Survival in Indolent Lymphoma
Fayad, L., Cabanillas, F., Talpaz, M., McLaughlin, P. J., & Kurzrock, R. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057568 · Cited by 50
Molecular Basis Underlying Functional Pleiotropy of Cytokines and Growth Factors
Hirano, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0609 · Cited by 47
Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma
Szczepek, A. J., Belch, A. R., & Pilarski, L. M. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00682-8 · Cited by 40
Speirs, V., Kerin, M. J., Walton, D. S., NEWTON, C. J., Desai, S. B., & Atkin, S. L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1097 · Cited by 35
Chen, L., Shulman, L. M., & Revel, M. (1992) · PubMed · Cited by 35
Nishimura, R., 長尾, 和., Miyayama, H., Matsuda, M., Baba, K., Matsuoka, Y., Yamashita, H., Fukuda, M., Mizumoto, T., & Hamamoto, R. (2000) · Oncology · doi:10.1159/000012155 · Cited by 33
IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES
Thabard, W., Collette, M., Mellerin, M., Puthier, D., Barillé‐Nion, S., Bataille, R., & Amiot, M. (2001) · Cytokine · doi:10.1006/cyto.2001.0911 · Cited by 28
Local Production of Interleukin 6 by Renal Adenocarcinoma In Vivo
Blay, J., Schemann, S., & Favrot, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.3.238 · Cited by 22
Salgado, R., Vermeulen, P., Marck, E. V., Benoy, I. H., & Dirix, L. Y. (2001) · PubMed · Cited by 7
Self-citationLong term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9
Cited by
Inflammation: The Common Pathway of Stress-Related Diseases
Liu, Y.-Z., Wang, Y.-X., & Jiang, C.-L. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00316 · Cited by 800
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 716
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Metadata
- Authors
- Salgado, R., Junius, S., Benoy, I., Van Dam, P., Vermeulen, P., Van Marck, E., Huget, P., & Dirix, L. Y.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-11-25
- Volume
- 103
- Issue
- 5
- Pages
- 642-646
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2028194167
- Cited by
- 435
- References
- 63
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.